| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Hannah Brendan | CBO, COO & CCO | C/O QUINCE THERAPEUTICS, INC., 611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO | /s/ Brendan Hannah | 20 Jun 2025 | 0001929422 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | QNCX | Common Shares | Award | $45,283 | +37,736 | +13% | $1.20 | 334,276 | 18 Jun 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | QNCX | Warrants | Award | $4,717 | +37,736 | $0.1250 | 37,736 | 18 Jun 2025 | Common Shares | 37,736 | $1.20 | Direct |